Tamtam Try Tamtam free
Reckitt logo

Reckitt account plan

Global leader in hygiene, wellness, and nutrition products for a cleaner, healthier world accessible to everyone.

At a glance

Reckitt is a UK consumer health and hygiene group (Dettol, Lysol, Durex, Finish) with FY2025 net revenue of £14,205mn and about 36k employees.

Reckitt is a UK-headquartered consumer health and hygiene group operating in 80 countries with an average of 36k employees. Its strategic core, Core Reckitt, is built around 11 Powerbrands in four categories: Self Care (Nurofen, Mucinex, Gaviscon, Strepsils), Germ Protection (Dettol, Lysol, Harpic), Household Care (Finish, Vanish) and Intimate Wellness (Durex, Veet). In FY2025 Group net revenue was £14,205mn (+5.0% like-for-like) and adjusted operating profit £3,543mn at a 24.9% margin. Essential Home was sold to Advent on 31 December 2025 (Reckitt keeps a 30% stake), and Mead Johnson Nutrition is managed as non-core while strategic options are assessed. Since 2025 the business is run through three Areas (Emerging Markets, Europe, North America), each with its own P&L.

Business units

Strategic priorities

Core Reckitt growth target
Core Reckitt is to deliver +4% to +5% like-for-like net revenue growth over the medium term, with annual EPS growth. FY2026 guidance was cut in October 2026 to +3.5% to +4.5%.
Portfolio streamlining
Essential Home (£1.9bn net revenue) was sold to Advent on 31 December 2025, the Russia Hygiene divestment is expected to complete in H2 2026, and strategic options for Mead Johnson Nutrition are still being assessed.
Fuel for Growth cost programme
Fixed costs fell from 21.8% of net revenue in 2023 to 19.4% in 2025, with a target below 19% by end-2027 for approximately £1 billion of one-off investment over 2024-2027, about £350 million of it in 2026. Remaining levers are shared service hubs in Warsaw, Mexico City and Hyderabad and digital and generative AI.
Emerging Markets and OTC expansion
Emerging Markets is the largest Area and is guided to high-single-digit growth for 2026. Reckitt is spreading sales methods from India and China and building its OTC portfolio, led by Gaviscon.
Brand investment and innovation
Brand Equity Investment rose to 14.6% of net revenue in 2025 and 15.3% in H1 2026. Recent launches include Mucinex 12HR Cold & Fever, Dettol Activ Botany, Durex Intensity and Vanish Turbo.
Market share
45% of top Category Market Units were holding or gaining share at H1 2026, against a 60% target; Mucinex US and Durex China were the two large units below that line.

Latest results

In H1 2026 (to 30 June) Group net revenue was £6,411m, -8.1% IFRS after the Essential Home sale but +2.6% like-for-like; Core Reckitt grew +2.7% LFL, accelerating to +4.2% in Q2. Core + MJN adjusted operating margin was 23.6% (-100bps) and adjusted diluted EPS 152.1p (-9.7%). In Q3 2026 Core Reckitt net revenue was £2,690m, +3.3% LFL (+3.9% excluding Russia Hygiene): Emerging Markets grew +8.0%, Europe returned to growth at +0.8% and North America fell -1.3% on Lysol supply constraints. FY2026 Core Reckitt guidance was trimmed to +3.5% to +4.5% LFL, with the Core + MJN adjusted operating margin kept at 24.9% to 25.6%.

Investments and deals

North America investment plan
Up to $600m multi-year investment announced in September 2026 for U.S.-based innovation, Healthcare access and supply resilience; 400 million builds a new Self Care factory in North Carolina and much of a further 200 million upgrades two hygiene plants.
China manufacturing and R&D
Expansion of the Taicang factory and a new Shanghai Science and Innovation Centre, the ninth global innovation hub.
Capex
Capex rose to £592 million in 2025 (2024: £465 million), including Mead Johnson regulatory and resilience investment; 2026 capex is guided at around 4% of net revenue.
Capital returns
£6.4bn returned to shareholders since July 2024, including a c.£1.6 billion special dividend paid in February 2026, and a new buyback of up to £500 million started on 5 August 2026.
Supply chain and SAP modernisation
SAP modernisation is under way, and Reckitt is building strategic inventory of solvents and plastics, moving sourcing and using more post-consumer recycled plastic.

Challenges and risks

Manufacturing capacity in North America
Line upgrades at the St. Peters hygiene plant caused longer-than-expected downtime on about four lines in Q3 2026, limiting Lysol supply despite strong demand.
Middle East input costs
The Middle East war raised input costs and forced temporary closure of the Bahrain plant; at Q1 a $110 oil scenario implied a c.£130 million - £150 million gross input-cost impact.
Promotional pressure in European Auto Dish
European Auto Dish is promotion-heavy and consumers are cutting volumes, with discounters gaining share; Household Care is elastic to price increases.
China competition
Cross-border VMS in China was roughly flat in Q3 2026 after false claims by smaller local competitors hurt consumer trust, and Durex was hit by VAT on condoms.
Heightened principal risks
The 2025 annual report flags product integrity, supply chain continuity, technology resilience and cyber, and geopolitical instability (tariffs, conflicts, shipping) as heightened risks.

What leadership says

“We have not historically invested as much in manufacturing as a company as I think we need to.”

Kris Licht, Chief Executive Officer · Q3 2026 trading update call, 27 October 2026

“We will probably have to price more at this level of commodity cost and input costs.”

Kris Licht, Chief Executive Officer · Q3 2026 trading update call, 27 October 2026

“There is more to do, but we have made real progress and our foundations are stronger.”

Kris Licht, Chief Executive Officer · Annual Report and Accounts 2025, March 2026

“a year of delivery against our strategic plan, of top and bottom-line growth and substantial cash returns to shareholders”

Shannon Eisenhardt, Chief Financial Officer · Annual Report and Accounts 2025, on FY2025

Where a supplier can help

Plant upgrades and supply resilience
Tied to the North America investment plan and the St. Peters downtime: suppliers of manufacturing equipment, line commissioning, maintenance and plant engineering can help bring new and upgraded lines on stream without further supply loss.
Shared services and automation
Tied to Fuel for Growth: the automation and shared services lever (hubs in Warsaw, Mexico City, Hyderabad) and SAP modernisation create openings for process automation, ERP and outsourcing partners.
Input cost and packaging sourcing
Tied to the Middle East input-cost challenge: suppliers of alternative solvents, plastics and post-consumer recycled packaging fit Reckitt's move to shift sourcing and build strategic inventory.
AI and sales force tools in Emerging Markets
Tied to the Emerging Markets priority: sales force automation and AI-enabled sales tools that widen distribution, as used in India, are being spread to other markets.
Consumer trust and brand protection in China
Tied to the China competition challenge: marketing, claims verification and media partners can support Reckitt's effort to restore trust in its US-manufactured VMS brands.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Reckitt?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Reckitt

What does Reckitt do?

Reckitt makes consumer health and hygiene products under 11 Powerbrands, including Dettol, Lysol, Harpic, Finish, Vanish, Durex, Veet, Nurofen, Gaviscon and Mucinex. It operates in 80 countries and also owns Mead Johnson Nutrition, which it treats as non-core.

What is Reckitt's revenue?

FY2025 Group net revenue was £14,205mn, +5.0% like-for-like, with adjusted operating profit of £3,543mn. In H1 2026, after the Essential Home sale, Group net revenue was £6,411m.

How many employees does Reckitt have?

Reckitt employed an average of 36k people in 2025.

What is Reckitt's strategy?

Reckitt is focusing on Core Reckitt's Powerbrands, targeting +4% to +5% like-for-like growth over the medium term, while divesting non-core businesses and cutting fixed costs below 19% of net revenue by end-2027 through Fuel for Growth.

Who leads Reckitt?

Kris Licht is Chief Executive Officer, Shannon Eisenhardt is Chief Financial Officer and Sir Jeremy Darroch is Chair.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)